Tomas Jan Heyman
Director/Miembro de la Junta en XILIO THERAPEUTICS, INC. .
Fortuna: 961 334 $ al 30/04/2024
Cargos activos de Tomas Jan Heyman
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AKERO THERAPEUTICS, INC. | Director/Miembro de la Junta | 09/06/2020 | - |
Independent Dir/Board Member | 09/06/2020 | - | |
OPTINOSE, INC. | Director/Miembro de la Junta | 01/12/2020 | - |
Independent Dir/Board Member | 01/12/2020 | - | |
LEGEND BIOTECH CORPORATION | Director/Miembro de la Junta | 02/08/2022 | - |
Independent Dir/Board Member | 02/08/2022 | - | |
XILIO THERAPEUTICS, INC. | Director/Miembro de la Junta | 15/09/2022 | - |
Independent Dir/Board Member | 15/09/2022 | - | |
EXELIXIS, INC. | Director/Miembro de la Junta | 31/05/2023 | - |
Independent Dir/Board Member | 31/05/2023 | - | |
Interlaken Therapeutics, Inc. | Director Ejecutivo | - | - |
Interuniversitair Micro-Electronica Centrum VZW
Interuniversitair Micro-Electronica Centrum VZW Miscellaneous Commercial ServicesCommercial Services Interuniversitair Micro-Electronica Centrum VZW, also known as Imec, is a Belgian business accelerator. The non-profit company is based in Leuven, BE and has subsidiaries in the United States, Taiwan, India, Netherlands, and Belgium. Imec.istart is their main program, which helps startups grow and succeed. The Belgian company was founded in 1984 and has been led by CEO Luc van den Hove since then. | Director/Miembro de la Junta | 27/04/2012 | - |
Historial de carrera de Tomas Jan Heyman
Antiguos cargos conocidos de Tomas Jan Heyman.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
INVIVYD, INC. | Director/Miembro de la Junta | 01/06/2021 | 21/05/2024 |
Independent Dir/Board Member | 01/06/2021 | 21/05/2024 | |
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Presidente | 07/03/2023 | 16/05/2024 |
░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░ ░░░░░░░ ░░░░░░░░░░ ░ ░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formación de Tomas Jan Heyman.
Katholieke Universiteit Leuven | Graduate Degree |
University of Antwerp | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 13 |
Bélgica | 5 |
Países Bajos | 2 |
Operativa
Director/Board Member | 10 |
Independent Dir/Board Member | 6 |
Chairman | 2 |
Sectorial
Health Technology | 11 |
Commercial Services | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 8 |
---|---|
JOHNSON & JOHNSON | Health Technology |
EXELIXIS, INC. | Health Technology |
OPTINOSE, INC. | Health Technology |
CVRX, INC. | Health Technology |
LEGEND BIOTECH CORPORATION | Health Technology |
XILIO THERAPEUTICS, INC. | Health Technology |
AKERO THERAPEUTICS, INC. | Health Technology |
INVIVYD, INC. | Health Technology |
Empresas privadas | 8 |
---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Commercial Services |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
International Biomedical Research Alliance
International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | Commercial Services |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Health Technology |
Ortho Pharmaceutical Corp. | |
Interuniversitair Micro-Electronica Centrum VZW
Interuniversitair Micro-Electronica Centrum VZW Miscellaneous Commercial ServicesCommercial Services Interuniversitair Micro-Electronica Centrum VZW, also known as Imec, is a Belgian business accelerator. The non-profit company is based in Leuven, BE and has subsidiaries in the United States, Taiwan, India, Netherlands, and Belgium. Imec.istart is their main program, which helps startups grow and succeed. The Belgian company was founded in 1984 and has been led by CEO Luc van den Hove since then. | Commercial Services |
Interlaken Therapeutics, Inc. |
- Bolsa de valores
- Insiders
- Tomas Jan Heyman
- Experiencia